Sign in
4

Changes in Ownership

Nuvectis Pharma, Inc. Filed Acc 0001104659-22-042820

Options or other derivatives

  • Director acquired 15,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Hoberman Kenneth · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-04-01 Grant or award : show line 1 in the form Stock Options (right to buy) +15,000 15,000 D
Loading xslF345X03/tm2211420-5_4seq1.xml…